ConductScience.org, home

Paper23949153

The value of high adherence to tamoxifen in women with breast cancer: a community-based cohort study.

McCowan C and 4 others. Br J Cancer, 2013. Cited by 112 papers, by iCite.

Cite this record

ConductScience Library. The value of high adherence to tamoxifen in women with breast cancer: a community-based cohort study. Papers, record 23949153. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23949153

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The value of high adherence to tamoxifen in women with breast cancer: a community-based cohort study.
PubMed
Journal
Br J Cancer
PubMed
Year
2013
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
112
iCite
Relative citation ratio, by iCite
3.56
iCite
Revised in PubMed
2022-04-09
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1McCowan CC
2Wang SS
3Thompson AMA M
4Makubate BB
5Petrie DJD J

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Agents, HormonalMajor topic
Breast NeoplasmsMajor topic
Medication AdherenceMajor topic
Neoplasm Recurrence, LocalMajor topic
TamoxifenMajor topic
Aged
Aged, 80 and over
Cohort Studies
Cost-Benefit Analysis
Female
Humans
Middle Aged
Quality of Life
Quality-Adjusted Life Years
Registries

Source PubMed

Download CSV of topics

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112586795Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer.J Clin Oncol2003https://conductscience.org/library/papers/12586795PubMed
212424066Tamoxifen non-compliance: does it matter?Lancet Oncol2002https://conductscience.org/library/papers/12424066PubMed
317592673Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in hormone receptor-positive postmenopausal women with early-stage breast cancer.Clin Breast Cancer2007https://conductscience.org/library/papers/17592673PubMed
41607900Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.J Clin Epidemiol1992https://conductscience.org/library/papers/1607900PubMed
520803066Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer.Breast Cancer Res Treat2011https://conductscience.org/library/papers/20803066PubMed
612472329Interventions to enhance patient adherence to medication prescriptions: scientific review.JAMA2002https://conductscience.org/library/papers/12472329PubMed
720921464Compliance with tamoxifen in women with breast cancer and a BRCA1 or BRCA2 mutation.J Clin Oncol2010https://conductscience.org/library/papers/20921464PubMed
820385997Effect of concomitant CYP2D6 inhibitor use and tamoxifen adherence on breast cancer recurrence in early-stage breast cancer.J Clin Oncol2010https://conductscience.org/library/papers/20385997PubMed
918155570Mortality impact of less-than-standard therapy in older breast cancer patients.J Am Coll Surg2008https://conductscience.org/library/papers/18155570PubMed
1023519057Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality.Br J Cancer2013https://conductscience.org/library/papers/23519057PubMed
1121802721Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.Lancet2011https://conductscience.org/library/papers/21802721PubMed
1217717337NICE's cost effectiveness threshold.BMJ2007https://conductscience.org/library/papers/17717337PubMed
1318985046Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer.Br J Cancer2008https://conductscience.org/library/papers/18985046PubMed
1420058066Half of breast cancer patients discontinue tamoxifen and any endocrine treatment before the end of the recommended treatment period of 5 years: a population-based analysis.Breast Cancer Res Treat2010https://conductscience.org/library/papers/20058066PubMed
1520585090Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients.J Clin Oncol2010https://conductscience.org/library/papers/20585090PubMed
1618071188Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer.J Clin Oncol2008https://conductscience.org/library/papers/18071188PubMed
1721450800Statin treatment for primary prevention of vascular disease: whom to treat? Cost-effectiveness analysis.BMJ2011https://conductscience.org/library/papers/21450800PubMed
1810204197Multiple imputation of missing blood pressure covariates in survival analysis.Stat Med1999https://conductscience.org/library/papers/10204197PubMed
1917243168Early discontinuation of tamoxifen: a lesson for oncologists.Cancer2007https://conductscience.org/library/papers/17243168PubMed
2018809051Noncompliance with adjuvant radiation, chemotherapy, or hormonal therapy in breast cancer patients.Am J Surg2008https://conductscience.org/library/papers/18809051PubMed

See all 29 referencesDownload CSV of references

Cited by86

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 112 citations.

PMIDTitleJournalYearIn PapersSource
42732184
Exploring trial acceptability, recruitment, and retention in a pilot optimisation randomised controlled trial of a behavioural intervention to support medication adherence in women with breast cancer: A qualitative process evaluation.
NIHR Open Res2026https://conductscience.org/library/papers/42732184PubMed
42108483Optimising a behavioural intervention to support endocrine therapy adherence for women with breast cancer: protocol for the ROSETA optimisation factorial randomised controlled trial.Trials2026https://conductscience.org/library/papers/42108483PubMed
41387699Mediators of the association between psychological distress and mortality in people diagnosed with cancer.Nat Commun2025https://conductscience.org/library/papers/41387699PubMed
41303890Adherence and Compliance with Endocrine Treatment After Primary Breast Cancer Treatment: A Cross-Sectional Qualitative Study.Medicina (Kaunas)2025https://conductscience.org/library/papers/41303890PubMed
41299751
Improving outcomeS for Women diagnosed with early breast cancer through adhErence to adjuvant Endocrine Therapy (SWEET): study protocol for a pragmatic randomised control trial of a patient-centred intervention to improve adherence to endocrine therapy in early breast cancer.
Trials2025https://conductscience.org/library/papers/41299751PubMed
40998714Management of menopausal symptoms following treatment for hormone receptor positive breast cancer.Br J Gen Pract2025https://conductscience.org/library/papers/40998714PubMed
40660375A community pharmacy-based program to enhance adherence to adjuvant endocrine therapy among breast cancer survivors (PACHA): protocol for a pilot cluster-randomized controlled trial.Pilot Feasibility Stud2025https://conductscience.org/library/papers/40660375PubMed
40356465Acceptability of acceptance and commitment therapy for medication-decision-making and quality of life in women with breast cancer: A qualitative process evaluation.Br J Health Psychol2025https://conductscience.org/library/papers/40356465PubMed
40093412Psychometric properties of instruments for assessing adherence to oral antineoplastic agents: a COSMIN systematic review.PeerJ2025https://conductscience.org/library/papers/40093412PubMed
40052001Group-Based Trajectory Modeling to Identify Patterns and Predictors of Adherence to Oral Endocrine Therapies in Underserved Population of Greater Houston Area.Patient Prefer Adherence2025https://conductscience.org/library/papers/40052001PubMed
39887069Supporting endocrine therapy adherence in women with breast cancer: findings from the ROSETA pilot fractional factorial randomized trial.Ann Behav Med2025https://conductscience.org/library/papers/39887069PubMed
39742356How to Optimize Deimplementation of Sentinel Lymph Node Biopsy?Breast J2024https://conductscience.org/library/papers/39742356PubMed
39682191Core Outcomes of Self-Care Behaviours in Patients with Breast Cancer Treated with Oral Anticancer Agents: A Systematic Review.Cancers (Basel)2024https://conductscience.org/library/papers/39682191PubMed
39657026Assessing multidimensional fidelity in a pilot optimization trial: A process evaluation of four intervention components supporting medication adherence in women with breast cancer.Transl Behav Med2025https://conductscience.org/library/papers/39657026PubMed
39642329Symptom Monitoring App Use Associated With Medication Adherence Among Woman Survivors of Breast Cancer on Adjuvant Endocrine Therapy.JCO Clin Cancer Inform2024https://conductscience.org/library/papers/39642329PubMed
39444481The Impact of Multidisciplinary Educational Team-Based Clinical Nursing Pathway on the Psychological Resilience, Treatment Adherence, Pain Management and Quality of Life in Cancer Patients.Iran J Public Health2024https://conductscience.org/library/papers/39444481PubMed
39106031Economic Assessment in Resource-Constrained Systems: Individual-Level Simulation Model in Wet Age-Related Macular Degeneration and Diabetic Macular Oedema.Ophthalmol Ther2024https://conductscience.org/library/papers/39106031PubMed
39060840Acceptability of Four Intervention Components Supporting Medication Adherence in Women with Breast Cancer: a Process Evaluation of a Fractional Factorial Pilot Optimization Trial.Prev Sci2024https://conductscience.org/library/papers/39060840PubMed
38916761Adherence to oral anticancer treatments: network and sentiment analysis exploring perceived internal and external determinants in patients with metastatic breast cancer.Support Care Cancer2024https://conductscience.org/library/papers/38916761PubMed
38637603Association between trajectories of adherence to endocrine therapy and risk of treated breast cancer recurrence among US nonmetastatic breast cancer survivors.Br J Cancer2024https://conductscience.org/library/papers/38637603PubMed

See all 86 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
EREG2069PubTator's text mininghttps://conductscience.org/library/genes/2069NCBI Gene
PGR5241PubTator's text mininghttps://conductscience.org/library/genes/5241NCBI Gene
TENM110178PubTator's text mininghttps://conductscience.org/library/genes/10178NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23949153

GET https://conductscience.org/api/papers/v1/23949153/references?page=2